Application 206952
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | CAPSULE, EXTENDED RELEASE; ORAL | 10MG | No | No |
| 005 | HYDROCODONE BITARTRATE | HYDROCODONE BITARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | 40MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hysingla ER | HYDROCODONE BITARTRATE | Knoa Pharma LLC | b7d23ac2-e776-9f62-3290-c64c2d6eb353 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | HYDROCODONE BITARTRATE |
| Hydrocodone Bitartrate | HYDROCODONE BITARTRATE | Alvogen Inc. | f7b55d14-0980-b680-8ceb-7489ff65455e | 2025-10-07 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate HYDROCODONE BITARTRATE |
| Hydrocodone Bitartrate | HYDROCODONE BITARTRATE | Alvogen Inc. | a7b8ea07-e926-f0a5-c20d-92f23ed350d0 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate HYDROCODONE BITARTRATE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 45819 | APPL | 2016-11-04 |